» Articles » PMID: 38532420

Recent Advances in Endothelial Colony-forming Cells: from the Transcriptomic Perspective

Overview
Journal J Transl Med
Publisher Biomed Central
Date 2024 Mar 27
PMID 38532420
Authors
Affiliations
Soon will be listed here.
Abstract

Endothelial colony-forming cells (ECFCs) are progenitors of endothelial cells with significant proliferative and angiogenic ability. ECFCs are a promising treatment option for various diseases, such as ischemic heart disease and peripheral artery disease. However, some barriers hinder the clinical application of ECFC therapeutics. One of the current obstacles is that ECFCs are dysfunctional due to the underlying disease states. ECFCs exhibit dysfunctional phenotypes in pathologic states, which include but are not limited to the following: premature neonates and pregnancy-related diseases, diabetes mellitus, cancers, haematological system diseases, hypoxia, pulmonary arterial hypertension, coronary artery diseases, and other vascular diseases. Besides, ECFCs are heterogeneous among donors, tissue sources, and within cell subpopulations. Therefore, it is important to elucidate the underlying mechanisms of ECFC dysfunction and characterize their heterogeneity to enable clinical application. In this review, we summarize the current and potential application of transcriptomic analysis in the field of ECFC biology. Transcriptomic analysis is a powerful tool for exploring the key molecules and pathways involved in health and disease and can be used to characterize ECFC heterogeneity.

Citing Articles

Isolation and Characterization of Endothelial-Colony Forming Cells (ECFC): Studying Endothelial Senescence for Translational Studies and for Personalized Medicine.

Paschalaki K, Pericleous C Methods Mol Biol. 2025; 2906:255-270.

PMID: 40082361 DOI: 10.1007/978-1-0716-4426-3_15.


A Personalized Approach to Vitamin D Supplementation in Cardiovascular Health Beyond the Bone: An Expert Consensus by the Italian National Institute for Cardiovascular Research.

Mattioli A, Coppi F, Severino P, Penna C, Pagliaro P, Dei Cas A Nutrients. 2025; 17(1.

PMID: 39796548 PMC: 11722835. DOI: 10.3390/nu17010115.


Bridging the Gap: Endothelial Dysfunction and the Role of iPSC-Derived Endothelial Cells in Disease Modeling.

Sgromo C, Cucci A, Venturin G, Follenzi A, Olgasi C Int J Mol Sci. 2025; 25(24.

PMID: 39769040 PMC: 11678083. DOI: 10.3390/ijms252413275.

References
1.
Kloosterman R, Zago-Schmitt M, Grabell J, Thibeault L, De Lima P, Bowman M . A transcriptome analysis of basal and stimulated VWF release from endothelial cells derived from patients with type 1 VWD. Blood Adv. 2022; 7(8):1477-1487. PMC: 10125911. DOI: 10.1182/bloodadvances.2022007884. View

2.
Chen C, Liao Y, Peng G . Connecting past and present: single-cell lineage tracing. Protein Cell. 2022; 13(11):790-807. PMC: 9237189. DOI: 10.1007/s13238-022-00913-7. View

3.
Schroder-Heurich B, Buder T, Meyer N, Vu T, Richter K, Ramachandran D . Downregulation of miR-1270 mediates endothelial progenitor cell function in preeclampsia: Role for ATM in the Src/VE-cadherin axis. FASEB J. 2022; 36(7):e22379. DOI: 10.1096/fj.202200040RR. View

4.
Haghverdi L, Lun A, Morgan M, Marioni J . Batch effects in single-cell RNA-sequencing data are corrected by matching mutual nearest neighbors. Nat Biotechnol. 2018; 36(5):421-427. PMC: 6152897. DOI: 10.1038/nbt.4091. View

5.
Chen K, Li Y, Xu L, Qian Y, Liu N, Zhou C . Comprehensive insight into endothelial progenitor cell-derived extracellular vesicles as a promising candidate for disease treatment. Stem Cell Res Ther. 2022; 13(1):238. PMC: 9172199. DOI: 10.1186/s13287-022-02921-0. View